Wacker Biotech US was established in 2021 when WACKER acquired the joint venture partnership known as Genopis, Inc. from Helixmith (formerly ViroMed) and Medivate. Its site in San Diego, California includes cGMP manufacturing operations, with currently capabilities suited for microbial-based products and expandable for future mammalian-based products. Wacker Biotech US specializes in plasmid DNA based technology and provides contract development and manufacturing organization (CDMO) opportunities to help your company reach its clinical and commercial goals.
The company is supported by staff members who have several decades of experience ranging from clinical start-up to commercial product companies. With our experience, our team provides the flexibility to transition rapidly in a fast-paced biotechnology environment and achieve the end goal, which is to provide medicine for our clients’ patients.
Provide services and products that meet the highest quality and compliance standards. Treat our customers like a team member, not just a business relationship. Be fiscally responsible in everything we do. Value our employees as our most important asset.
So that our contributions provide patients, their families, and our employees time to connect, love and laugh!
Customer Focus: We are deeply committed to meeting the needs of our customers.
Integrity: We demand of ourselves the highest ethical standards.
Respect for people: We acknowledge that our employees are the cornerstone of our success and we will always treat each other with respect and dignity.
Teamwork: We know that to be a successful company we must all work together towards common goals.
Passion for our work: We are enthusiastic and committed to our work.
Innovation, Creativity: We strive to be innovative and creative, focusing on the most efficient systems and methods while working to the highest Quality standards.